Zhejiang Xinguang Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 44.77%

Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has an Asset Resilience Ratio of 44.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Zhejiang Xinguang Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥400.00 Million

≈ $58.53 Million USD Cash + Short-term Investments

Total Assets

CN¥893.41 Million

≈ $130.73 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Zhejiang Xinguang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Zhejiang Xinguang Pharmaceutical Co Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Xinguang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Zhejiang Xinguang Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥400.00 Million	44.77%
Total Liquid Assets	CN¥400.00 Million	44.77%

Asset Resilience Insights

Very High Liquidity: Zhejiang Xinguang Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 44.77% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Xinguang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Xinguang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Zhejiang Xinguang Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Xinguang Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	20.33%	CN¥185.00 Million ≈ $27.07 Million	CN¥909.78 Million ≈ $133.13 Million	+3.68pp
2023-12-31	16.66%	CN¥155.00 Million ≈ $22.68 Million	CN¥930.41 Million ≈ $136.15 Million	+4.65pp
2022-12-31	12.01%	CN¥115.00 Million ≈ $16.83 Million	CN¥957.76 Million ≈ $140.15 Million	-1.40pp
2021-12-31	13.41%	CN¥125.00 Million ≈ $18.29 Million	CN¥932.40 Million ≈ $136.44 Million	+3.86pp
2020-12-31	9.54%	CN¥85.00 Million ≈ $12.44 Million	CN¥890.79 Million ≈ $130.35 Million	-15.77pp
2019-12-31	25.32%	CN¥218.00 Million ≈ $31.90 Million	CN¥861.13 Million ≈ $126.01 Million	+3.67pp
2018-12-31	21.64%	CN¥178.00 Million ≈ $26.05 Million	CN¥822.50 Million ≈ $120.36 Million	-0.03pp
2017-12-31	21.68%	CN¥168.00 Million ≈ $24.58 Million	CN¥775.05 Million ≈ $113.41 Million	+0.28pp
2016-12-31	21.40%	CN¥150.00 Million ≈ $21.95 Million	CN¥700.95 Million ≈ $102.57 Million	--

pp = percentage points

About Zhejiang Xinguang Pharmaceutical Co Ltd

SHE:300519 China Drug Manufacturers - Specialty & Generic

Market Cap

$325.91 Million

CN¥2.23 Billion CNY

Market Cap Rank

#14538 Global

#4352 in China

Share Price

CN¥13.92

Change (1 day)

+0.07%

52-Week Range

CN¥11.85 - CN¥17.56

All Time High

CN¥52.02